The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "Anthem" ...
-
Oh Say Can You See?
Tisha Thompson gathered a team of experts, historians, sailors and volunteers to help her re-enact Francis Scott Key's journey during the Battle of Fort McHenry, to see if it was actually possible that he saw the American flag when he wrote the Star Spangled Banner. The investigation found that it was not likely for him to have spotted the flag.
Tags: patriotism; national anthem; fourth of July; history; re-enactment
-
"Bed Check: HMO Rates Hospitals; Many Don't Like It, But They Get Better"
Burton looks at a study of cardiac units in Ohio hospitals by Anthem Blue Cross & Blue Shield. Surprisingly, he says, the study's rankings show a relatively unknown hospital to have the best care for heart surgery patients, while the more famous clinics don't score so well. He traces the fallout from the study's announcements.
Tags: Anthem; Blue Cross; Blue Shield; cardiac; heart; rankings; mortality; nurse; doctor; surgery; surgeon; Ohio State; St. Elizabeth
-
FDA and Drug Safety
A CBS investigative series reports on different aspects of dangerous medicine. Some of the reports reveal that the managed care has gone out of control. "Health insurance giants ... are harming patients by denying crucial medical care, illegally denying and delaying claims, and using unfair and deceptive trade practices." Insurers also "downcode" doctors' claims - that is, change them to services that pay less or nothing at all. Other stories look at the risks posed by drug studies and the lack of enough oversight from the Food and Drug Administration (FDA). One of the reports tells how a healthy baby died after being enrolled in a study of Propulsid, a heartburn drug that turned out to be dangerous and has been repeatedly rejected by the FDA for pediatric use. The series also examine cases of prescription drugs that should have never been sold, and concludes that FDA has become too close to the pharmaceutical industry. A major finding is that pharmaceutical companies in the U.S. have huge financial incentives to keep dangerous drugs on the market at the cost of patients' deaths and injuries.
Tags: TAPE; TRANSCRIPT; medicine; HMOs; health care; patients; Cigna; Oxford; Connecticare; Aetna; Physician Health Services; Anthem Bule Cross/Blue Shield; Rezulin; Pfeizer; Warner Lambert